Brand: Coherus BioSciences (for LOQTORZI) · SKU: J3263 · MPN: J3263 · Category: Components
J3263 is the HCPCS code designated for the drug Injection, toripalimab-tpzi (LOQTORZI), 1 mg, effective for dates of service on or after July 1, 2024. Toripalimab-tpzi is indicated for recurrent, locally advanced nasopharyngeal carcinoma (NPC) after progression on or after a platinum-containing chemotherapy. The NDC associated is 70114-0340-01. Some payers may prefer the use of code 96365. For questions regarding LOQTORZI billing and coding, contact LOQTORZI Solutions at 1-844-483-3692.
| NDC | 70114-0340-01 |
|---|---|
| Drug Name | Toripalimab-tpzi |
| HCPCS Code | J3263 |
| Trade Name | LOQTORZI |
| Effective Date | July 1, 2024 |
| Unit of Measure | 1 mg |
| Warranty | N/A |
| Weight | N/A |
| Dimensions | N/A |
J3263 is the specific Healthcare Common Procedure Coding System (HCPCS) code for the injection of Toripalimab-tpzi (LOQTORZI), 1 mg, used in the treatment of recurrent, locally advanced nasopharyngeal carcinoma (NPC).
Yes, this Toripalimab-tpzi (LOQTORZI) - HCPCS Code (J3263) is 100% genuine Coherus BioSciences (for LOQTORZI) hardware. All our products are verified by certified technicians and come with clean serial numbers ready for service contract registration.
This Toripalimab-tpzi (LOQTORZI) - HCPCS Code includes our standard 3-Year Warranty covering all manufacturing defects. We also offer advanced replacement options for minimal downtime.
We offer free ground shipping which typically takes 3-5 business days. Expedited shipping options are available at checkout for faster delivery.
Yes, we have a 30-day return policy on all products. Restocking fees may apply for opened items. Please see our return policy for complete details.
Please check the specifications tab for detailed compatibility information. Our technical team is available to assist with compatibility questions for the J3263.